Document is current
Any future updates will be listed below
-
Authors
Lotthammer, Jeffrey M. http://orcid.org/0000-0002-5022-7006
Ginell, Garrett M. http://orcid.org/0000-0001-6511-5480
Griffith, Daniel http://orcid.org/0000-0002-9633-9601
Emenecker, Ryan J.
Holehouse, Alex S. http://orcid.org/0000-0002-4155-5729
-
Funding
Funding for this research was provided by:
Human Frontier Science Program (RGP0015/2022)
Longer Life Foundation
NSF | BIO | Division of Molecular and Cellular Biosciences (2128068, 2139839, 2139839)
NSF | BIO | Division of Biological Infrastructure (2213983)
Milli Sigma Foundation Fellowship
- License Information
-
More Information
Article History
Received: 28 May 2023
Accepted: 20 December 2023
First Online: 31 January 2024
Competing interests
: A.S.H. is a scientific consultant with Dewpoint Therapeutics and is on the Scientific Advisory Board of Prose Foods. The work reported here was not influenced by these affiliations. All other authors declare no competing interests.
